Literature DB >> 8974637

Glucose attenuation of atropine-induced deficits in paradoxical sleep and memory.

W S Stone1, R J Rudd, P E Gold.   

Abstract

When administered systemically, glucose attenuates deficits in memory produced by several classes of drugs, including cholinergic antagonists and opiate agonists. Glucose also enhances memory in aged rats, mice, and humans. In addition, glucose ameliorates age-related reductions in paradoxical sleep. Because deficits in paradoxical sleep are most marked in those individual aged rats that also have deficits in memory, treatments which improve one of these functions may similarly improve the other. The present experiments show that glucose attenuates deficits in paradoxical sleep and memory after atropine administration, with similar dose-response curves for both actions. In the first experiment, rats received saline, atropine (1 mg/kg), glucose (100 mg/kg) or combinations of atropine + glucose (10, 100, 250, and 500 mg/kg) 30 min before assessment on a spontaneous alternation task. In the second experiment, 3-h EEGs were assessed for spontaneous daytime sleep in rats administered saline, atropine (1 mg/kg), glucose (100 mg/kg) or combinations of atropine + glucose (10, 100 and 250 mg/kg). In both experiments, glucose significantly attenuated deficits at an optimal dose of 100 mg/kg. A third experiment assessed blood glucose levels after injections of atropine + glucose (100 mg/kg) and determined that blood glucose levels were similar to those produced by other treatments which enhance memory. These results are consistent with the view that paradoxical sleep and at least one test of memory are similarly influenced by atropine and glucose.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8974637     DOI: 10.1016/0006-8993(95)00810-d

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  7 in total

Review 1.  Retrieval of attention-dependent long-term memory traces.

Authors:  V I Arkhipov
Journal:  Neurosci Behav Physiol       Date:  1999 Nov-Dec

2.  Decreases in rat extracellular hippocampal glucose concentration associated with cognitive demand during a spatial task.

Authors:  E C McNay; T M Fries; P E Gold
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  Glucose attenuates impairments in memory and CREB activation produced by an α4β2 but not an α7 nicotinic receptor antagonist.

Authors:  Ken A Morris; Sisi Li; Duat D Bui; Paul E Gold
Journal:  Neuropharmacology       Date:  2012-11-16       Impact factor: 5.250

4.  Modulation of hippocampal acetylcholine release and spontaneous alternation scores by intrahippocampal glucose injections.

Authors:  M E Ragozzino; S N Pal; K Unick; M R Stefani; P E Gold
Journal:  J Neurosci       Date:  1998-02-15       Impact factor: 6.167

5.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

6.  Hippocampal acetylcholine release during memory testing in rats: augmentation by glucose.

Authors:  M E Ragozzino; K E Unick; P E Gold
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

7.  Naloxone modulates the behavioral effects of cholinergic agonists and antagonists.

Authors:  D L Walker; T McGlynn; C Grey; M Ragozzino; P E Gold
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.